These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20124412)

  • 1. Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men.
    van Raalte DH; Nofrate V; Bunck MC; van Iersel T; Elassaiss Schaap J; Nässander UK; Heine RJ; Mari A; Dokter WH; Diamant M
    Eur J Endocrinol; 2010 Apr; 162(4):729-35. PubMed ID: 20124412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial.
    van Genugten RE; van Raalte DH; Muskiet MH; Heymans MW; Pouwels PJ; Ouwens DM; Mari A; Diamant M
    Eur J Endocrinol; 2014 Mar; 170(3):429-39. PubMed ID: 24297090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial metabolic responses to mixed versus liquid meal tests in healthy men and men with type 2 diabetes.
    Brodovicz KG; Girman CJ; Simonis-Bik AM; Rijkelijkhuizen JM; Zelis M; Bunck MC; Mari A; Nijpels G; Eekhoff EM; Dekker JM
    Diabetes Res Clin Pract; 2011 Dec; 94(3):449-55. PubMed ID: 21955958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction.
    den Uyl D; van Raalte DH; Nurmohamed MT; Lems WF; Bijlsma JW; Hoes JN; Dijkmans BA; Diamant M
    Arthritis Rheum; 2012 Mar; 64(3):639-46. PubMed ID: 21953589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function.
    Alba M; Ahrén B; Inzucchi SE; Guan Y; Mallick M; Xu L; O'Neill EA; Williams-Herman DE; Kaufman KD; Goldstein BJ
    Diabetes Obes Metab; 2013 Dec; 15(12):1101-10. PubMed ID: 23782502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high-frequency insulin pulsatility in humans.
    Hollingdal M; Juhl CB; Dall R; Sturis J; Veldhuis JD; Schmitz O; Pørksen N
    Diabetologia; 2002 Jan; 45(1):49-55. PubMed ID: 11845223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3309-17. PubMed ID: 20410219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?
    van Raalte DH; Kwa KA; van Genugten RE; Tushuizen ME; Holst JJ; Deacon CF; Karemaker JM; Heine RJ; Mari A; Diamant M
    Metabolism; 2013 Apr; 62(4):568-77. PubMed ID: 23164480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial.
    van Raalte DH; Diamant M; Ouwens DM; Ijzerman RG; Linssen MM; Guigas B; Eringa EC; Serné EH
    Diabetologia; 2013 Nov; 56(11):2383-91. PubMed ID: 23933953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea.
    Mari A; Nielsen LL; Nanayakkara N; DeFronzo RA; Ferrannini E; Halseth A
    Horm Metab Res; 2006 Dec; 38(12):838-44. PubMed ID: 17163361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids.
    Hoes JN; van der Goes MC; van Raalte DH; van der Zijl NJ; den Uyl D; Lems WF; Lafeber FP; Jacobs JW; Welsing PM; Diamant M; Bijlsma JW
    Ann Rheum Dis; 2011 Nov; 70(11):1887-94. PubMed ID: 21908880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.
    Xu L; Man CD; Charbonnel B; Meninger G; Davies MJ; Williams-Herman D; Cobelli C; Stein PP
    Diabetes Obes Metab; 2008 Dec; 10(12):1212-20. PubMed ID: 18476982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
    Rosenstock J; Foley JE; Rendell M; Landin-Olsson M; Holst JJ; Deacon CF; Rochotte E; Baron MA
    Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No difference in glycosphingolipid metabolism and mitochondrial function in glucocorticoid-induced insulin resistance in healthy men.
    Brands M; van Raalte DH; João Ferraz M; Sauerwein HP; Verhoeven AJ; Aerts JM; Diamant M; Serlie MJ
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1219-25. PubMed ID: 23386653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute and chronic glucocorticoid therapy on insulin sensitivity and postprandial vascular function.
    Radhakutty A; Mangelsdorf BL; Drake SM; Samocha-Bonet D; Jenkins AB; Heilbronn LK; Smith MD; Thompson CH; Burt MG
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):501-8. PubMed ID: 26493042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose prednisolone and insulin sensitivity differentially affect arterial stiffness and endothelial function: An open interventional and cross-sectional study.
    Petersons CJ; Mangelsdorf BL; Poljak A; Smith MD; Greenfield JR; Thompson CH; Burt MG
    Atherosclerosis; 2017 Mar; 258():34-39. PubMed ID: 28189039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial.
    Wasko MC; McClure CK; Kelsey SF; Huber K; Orchard T; Toledo FG
    Diabetologia; 2015 Oct; 58(10):2336-43. PubMed ID: 26197707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.
    van Raalte DH; Brands M; van der Zijl NJ; Muskiet MH; Pouwels PJ; Ackermans MT; Sauerwein HP; Serlie MJ; Diamant M
    Diabetologia; 2011 Aug; 54(8):2103-12. PubMed ID: 21562755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.